Vivo Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Vivo Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 7, 2023	Digibee	$60.0M Series B	Natan Reinig	G2D, Kinea, Leadwind, Southern Europe, Vivo Capital
Mar 1, 2022	Klavi	$15.0M Series A	Iporanga Ventures	Bond, Parallax Ventures, Eduardo Wurzmann, Joao Otavio Oliverio, CIP, GSR Ventures
Oct 1, 2014	Aclaris Therapeutics	$21.0M Series B	—	F-Prime Capital Partners, Frazier Healthcare Partners, F-Prime Capital, Sofinnova Ventures
Apr 2, 2013	Revance Therapeutics	$104.0M Other Equity / Series E	—	Bio*One Capital, Delphi Ventures, NovaQuest Capital Management, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners
Oct 1, 2012	Aclaris Therapeutics	$21.0M Series A	Ketan Patel, Albert Cha	F-Prime Capital Partners, Frazier Healthcare Partners, Sofinnova Ventures
Jun 1, 2012	SentreHEART	$26.0M Series C	Chen Yu	U.S. Venture Partners, Prospect Venture Partners
Jun 1, 2012	Ceptaris Therapeutics	$10.0M Series D	—	Frazier Healthcare Partners, Aperture Venture Partners, BioAdvance, Burrill & Company, Osage Venture Partners, Palo Alto Investors, Third Point
Jan 1, 2012	AirXpanders	$10.0M Series D	Albert Cha	Frazier Healthcare Partners, Vivo Capital, GBS Venture Partners, Heron Capital, Prolog Ventures, Western Technology Investment
Nov 16, 2011	Medley Health	$20.0M Series A	—	Thomas G. McKinley, Jim Glasheen, Albert Cha
Nov 1, 2011	Rempex Pharmaceuticals	$68.0M Series B	—	Frazier Healthcare Partners, OrbiMed, Adams Street Partners, SV Health Investors
Aug 1, 2011	Ceptaris Therapeutics	$14.0M Series D	—	Frazier Healthcare Partners, Aperture Venture Partners, Burrill & Company, Palo Alto Investors
Jun 10, 2011	Revance Therapeutics	$45.0M Other Equity	Jonathan Tunnicliffe	CNF Investments, Essex Capital Corporation, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners
Jan 11, 2011	NextWave Pharmaceuticals	$45.0M Series C	Dayton Misfeldt, Gaurav Aggarwal	Aisling Capital, F-Prime Capital, Kearny Venture Partners, Sofinnova Ventures
Jun 1, 2010	Vicept Therapeutics	$16.0M Series A	F-Prime Capital, Sofinnova Ventures, Vivo Ventures	Frazier Healthcare Partners
Jan 1, 2010	Revance Therapeutics	$26.0M Series D	—	Vivo Capital, Bio*One Capital, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners
Oct 23, 2008	Nora Therapeutics	$25.0M Other Equity	—	Burrill & Company, Prospect Venture Partners